European funds - Realized Project

"Developing services, products and increasing the level of security of sensitive data in the field of clinical trials at the PI-House Clinical Research Center Ltd"

Project goals:
1. Offer of a new geriatrics clinical research service and diagnostic research products,
2. Improving the quality of clinical trials offer services provided so far,
3. Increasing export sales.

Planned effects:
1. Higher efficiency and operational safety
2. Higher export sales

Awaited results:
1. Optimization, improvement and acceleration of processes in the company (lower operating costs, saving employees time, better control over
processes)
2. Modernization of the company in the area of service offer development,
3. Higher product quality due to improved service provision process.

 

Project value:  PLN 110,050.00

Project co-financing from the EU:  PLN 53 924.50

Beneficiary's own contribution:  PLN 56 125.50

Close Menu
en_GBEnglish (UK)
pl_PLPolski en_GBEnglish (UK)

Personal Data Protection Personal data protection

We have a personal data protection policy in accordance with the GDPR. This site uses cookies to provide services at the highest level. By continuing to use the site, you agree to their use.

Personal Data Administrator is Centrum Badań Klinicznych PI-House Sp. z o. o with its registered office in Gdańsk (80-546), ul. Na Zaspa 3, registered in the Gdańsk-Północ District Court in Gdańsk, VII Commercial Department of the National Court Register under the number KRS: 0000394618, NIP: 9571059089.

Please be advised that the Data Administrator has appointed a Personal Data Protection Inspector. You have the right to contact the Data Protection Officer directly using the email address: iod@pihouse.pl.

Learn more by clicking this link

We run a policy of personal data protection according to ROPE.
Our website uses cookies to improve your experience. By continuing to browse our website, you are agreeing to our use of cookies.
The administrator of Personal Data is the Centrum Badań Klinicznych PI-House Sp. z o. o. with headquarters in Gdańsk (80-546), ul. Na Zaspa 3, registered at the District Court Gdańsk - Północ in Gdańsk, VII Commercial Division of the National Court Register under KRS number: 0000394618, Taxpayer identification number: 9571059089.
Please be advised that the Data Administrator has appointed the Data Protection Inspector. You have the right to contact the Data Protection Supervisor using the e-mail address: iod@pihouse.pl.
Learn more by clicking this link

Basic information
Ladies and Gentlemen, answering the questions contained in the survey below will allow us to choose the right diagnostic and medical consultation proposal for you. Participation in our free research programs is completely voluntary.
Please list all medications you are currently taking along with the doses:
I consent to the processing of my personal data, including sensitive data, based on the GDPR Art. 6 point a. in order to protect my health, provide medical services to me and conduct medical clinical trials by the Centrum Badań Klinicznych PI-House sp. z o.o. with headquarters in Gdańsk, ul. Na Zaspa 3. Consent to the processing of my personal data also includes consent to their processing in the future, provided that the purpose of processing does not change. I have been informed about the right to view and correct data and to obtain information on the data collected. At the same time, I agree to the use of my data, including sensitive data, to: inform me about the possibility of participating in free preventive examinations, assessing the possibility of qualifying me for clinical tests and inviting me to participate in such examination. I agree to receive information about the offer of preventive tests or clinical tests and about upcoming visits to the PI-House Clinical Research Center with the use of means of distance communication in the form of telephone contact, email, sms or written notification addressed to the address I provided. I consent to the processing of my data for the purposes and scope indicated in this consent in IT systems.